MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development

Core Insights - MedX Health Corp. has appointed Dr. Symon D. Cotton as Strategic Advisor on AI and Product Development, enhancing its leadership in teledermatology and non-invasive skin analysis [1][5][6] Company Overview - MedX Health Corp. is a leader in non-invasive skin assessment and teledermatology, utilizing its proprietary SIAscopy® technology integrated into the DermSecure® platform for accurate imaging of skin lesions [6] - The company’s products are cleared for use in 38 territories worldwide, including Canada, the U.S., Australia, and the European Union [6] Appointment of Dr. Symon Cotton - Dr. Cotton is recognized for his contributions to medical technology innovation and has a background in engineering, biology, and computation [2][4] - He played a key role in the development of SIAscopy®, the first technology for non-invasive measurement of melanin, hemoglobin, and collagen in the skin [3] - His expertise in AI-driven analytics and medical imaging aligns with MedX's strategic goals to enhance diagnostic accuracy and scalability [4] Strategic Goals - Dr. Cotton aims to leverage MedX's imaging database and DermSecure® platform to improve early skin cancer detection globally [5] - The CEO of MedX, John Gevisser, emphasized that Dr. Cotton's experience will help maintain the company's leadership in skin optics and machine learning [5]